Ensituximab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Ensituximab ?
Monoclonal antibody
Type Whole antibody
Source Chimeric (mouse/human)
Target 5AC
Clinical data
Legal status
?
Identifiers
CAS number 1092658-06-4 N
ATC code None
UNII F988K568V2 YesY
Chemical data
Formula C6342H9800N1678O1985S46 
Mol. mass 142.8 kDa
 N (what is this?)  (verify)

Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.[1]

Ensituximab was developed by Neogenix Oncology, Inc.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Ensituximab". American Medical Association.